SCHEMBL9365789

SCHEMBL9365789

N#CC1C=Cc2ccccc2N1C(=O)c1ccc(Cl)cc1

nearest known ligand 0.72

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.72
▸ LMNA P02545 4/20 0.72
▸ MEN1 O00255 4/20 0.72
▸ ALDH1A1 P00352 3/20 0.72
▸ SMN1; SMN2 Q16637 3/20 0.60
▸ NPSR1 Q6W5P4 2/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ P2RX4 Q99571 2/20 0.41
▸ ATM Q13315 2/20 0.39
▸ HPGD P15428 1/20 0.39
▸ PTGDR2 Q9Y5Y4 1/20 0.39
▸ MGLL Q99685 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29624123 1.00 KMT2A (0.72) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL8342494 0.89 LMNA (0.75) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL9369302 0.88 LMNA (0.78) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL9365388 0.87 LMNA (0.72) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL4429170 0.87 LMNA (0.67) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL8342323 0.87 LMNA (0.72) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL9365729 0.87 LMNA (0.72) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL8345917 0.85 LMNA (0.78) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL8342786 0.84 LMNA (0.68) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL8343305 0.84 LMNA (0.68) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2846788-A1 USE OF COMPOUNDS FOR THE TREATMENT OF PAIN Akron Molecules AG (AT) 2015-03-18 — — EP disclosed
WO-2013167743-A1 USE OF COMPOUNDS FOR THE TREATMENT OF PAIN AKRON MOLECULES GMBH (AT) 2013-11-14 — — WO disclosed
EP-0579695-A1 REISSERT COMPOUNDS AS ANTI-HIV AGENTS THE UPJOHN COMPANY (US) 1994-01-26 — — EP disclosed
WO-1992016508-A1 REISSERT COMPOUNDS AS ANTI-HIV AGENTS THE UPJOHN COMPANY (US) 1992-10-01 — — WO disclosed
Send feedback